It is possible that these events are related to energy metabolism alterations which have been well studied in normal cells and in many diseases, including cardiovascular diseases and cancer, in which PPARα has been suggested as a therapeutic target [10], [17], [37], [38]. The gene discussed is PPARA; the disease is cardiovascular disorder.